Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol®
- 1 August 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (3) , 279-284
- https://doi.org/10.1016/0002-9149(90)90836-p
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Preservation of left ventricular ejection fraction during percutaneous transluminal coronary angioplasty by distal transcatheter coronary perfusion of oxygenated fluosol DA 20%American Heart Journal, 1988
- Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%.Circulation, 1986
- Regional myocardial dysfunction during coronary angioplasty: Evaluation by two-dimensional echocardiography and 12 lead electrocardiographyJournal of the American College of Cardiology, 1986
- Echocardiographic evaluation of left ventricular function during coronary artery angioplastyThe American Journal of Cardiology, 1986
- Distal coronary artery perfusion during percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1985
- Sequence of mechanical, electrocardiographic and clinical effects of repeated coronary artery occlusion in human beings: Echocardiographic observations during coronary angioplastyJournal of the American College of Cardiology, 1985
- Left ventricular performance, regional blood flow, wall motion, and lactate metabolism during transluminal angioplasty.Circulation, 1984
- Prolonged application of pressure in transluminal coronary angioplastyCatheterization and Cardiovascular Diagnosis, 1984
- The stunned myocardium: prolonged, postischemic ventricular dysfunction.Circulation, 1982
- Clinical Studies of A Perfluorochemical Whole Blood Substitute (Fluosol-DA)Annals of Surgery, 1982